Safety of xylo-oligosaccharides (XOS) as ...
Document type :
Article dans une revue scientifique: Article original
DOI :
PMID :
Permalink :
Title :
Safety of xylo-oligosaccharides (XOS) as a novel food pursuant to Regulation (EU) 2015/2283
Author(s) :
Turck, Turck [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Bresson, Jean-Louis [Auteur]
Burlingame, Barbara [Auteur]
Dean, Tara [Auteur]
Fairweather-Tait, Susan [Auteur]
Heinonen, Marina [Auteur]
Hirsch-Ernst, Karen-Ildico [Auteur]
Mangelsdorf, Inge [Auteur]
Mcardle, Harry J. [Auteur]
Naska, Androniki [Auteur]
Neuhauser-Berthold, Monika [Auteur]
Nowicka, Grazyna [Auteur]
Pentieva, Kristina [Auteur]
Sanz, Yolanda [Auteur]
Siani, Alfonso [Auteur]
Sjodin, Anders [Auteur]
Stern, Martin [Auteur]
Tome, Daniel [Auteur]
Vinceti, Marco [Auteur]
Willatts, Peter [Auteur]
Engel, Karl-Heinz [Auteur]
Marchelli, Rosangela [Auteur]
Poting, Annette [Auteur]
Poulsen, Morten [Auteur]
Schlatter, Josef Rudolf [Auteur]
Turla, Emanuela [Auteur]
Van Loveren, Henk [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Bresson, Jean-Louis [Auteur]
Burlingame, Barbara [Auteur]
Dean, Tara [Auteur]
Fairweather-Tait, Susan [Auteur]
Heinonen, Marina [Auteur]
Hirsch-Ernst, Karen-Ildico [Auteur]
Mangelsdorf, Inge [Auteur]
Mcardle, Harry J. [Auteur]
Naska, Androniki [Auteur]
Neuhauser-Berthold, Monika [Auteur]
Nowicka, Grazyna [Auteur]
Pentieva, Kristina [Auteur]
Sanz, Yolanda [Auteur]
Siani, Alfonso [Auteur]
Sjodin, Anders [Auteur]
Stern, Martin [Auteur]
Tome, Daniel [Auteur]
Vinceti, Marco [Auteur]
Willatts, Peter [Auteur]
Engel, Karl-Heinz [Auteur]
Marchelli, Rosangela [Auteur]
Poting, Annette [Auteur]
Poulsen, Morten [Auteur]
Schlatter, Josef Rudolf [Auteur]
Turla, Emanuela [Auteur]
Van Loveren, Henk [Auteur]
Journal title :
EFSA Journal
Abbreviated title :
EFSA J.
Volume number :
16
Publication date :
2018-07
ISSN :
1831-4732
English keyword(s) :
Safety
XOS
novel food
xylo-oligosaccharides
XOS
novel food
xylo-oligosaccharides
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver a scientific opinion on a mixture of xylo-oligosaccharides (XOS) as a novel food ...
Show more >Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver a scientific opinion on a mixture of xylo-oligosaccharides (XOS) as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is obtained from corncobs (Zea mays subsp. mays) via enzyme-catalysed hydrolysis and subsequent purification. The main components of the NF, the oligosaccharides, are resistant to human digestive enzymes and are fermented by colonic bacteria. The intention is to add the NF to a variety of foods such as bakery and dairy products, fruit jelly, chocolates and soy-drinks. The information provided on composition, specifications, production process and stability of the NF, does not raise safety concerns. There were effects observed in the animal studies with the NF or with other XOS which were considered by the Panel to be expected from the intake of non-digestible carbohydrates. The Panel notes that the acute and transient gastrointestinal observed in human intervention studies with the NF or with other XOS have also been associated with the consumption of other non-digestible carbohydrates. The Panel concludes that the NF, a mixture of XOS, is safe under the proposed uses and use levels. The target population is the general population.Show less >
Show more >Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver a scientific opinion on a mixture of xylo-oligosaccharides (XOS) as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is obtained from corncobs (Zea mays subsp. mays) via enzyme-catalysed hydrolysis and subsequent purification. The main components of the NF, the oligosaccharides, are resistant to human digestive enzymes and are fermented by colonic bacteria. The intention is to add the NF to a variety of foods such as bakery and dairy products, fruit jelly, chocolates and soy-drinks. The information provided on composition, specifications, production process and stability of the NF, does not raise safety concerns. There were effects observed in the animal studies with the NF or with other XOS which were considered by the Panel to be expected from the intake of non-digestible carbohydrates. The Panel notes that the acute and transient gastrointestinal observed in human intervention studies with the NF or with other XOS have also been associated with the consumption of other non-digestible carbohydrates. The Panel concludes that the NF, a mixture of XOS, is safe under the proposed uses and use levels. The target population is the general population.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
CHU Lille
Inserm
Université de Lille
Inserm
Université de Lille
Submission date :
2019-10-22T08:09:49Z
2023-12-08T15:43:50Z
2023-12-08T15:43:50Z
Files
- EFSA Journal - 2018 - - Safety of xylo‐oligosaccharides XOS as a novel food pursuant to Regulation EU 2015 2283.pdf
- Non spécifié
- Open access
- Access the document
Except where otherwise noted, this item's license is described as Attribution-NoDerivs 3.0 United States